EIF2AK3 and Alzheimer disease: A recent study reported that in the brains of Down Syndrome patients (who have a high propensity to develop AD), there is sustained activation of the PERK pathway, but it fails to regulate anti-oxidant outcomes through Nrf2, therefore exacerbating oxidative stress [52].